Dicerna Pharmaceuticals, Inc.’s Post

Today, Novo Nordisk completed the acquisition of Dicerna.

Press release

Press release

Marc Abrams

CSO at Carbon Biosciences

2y

Congrats to the Novo and Dicerna teams. And a special thank you to Dicerna R&D who’s hard work, talent and dedication enabled this - DIscovery Research, Translational Biollogy, Partnered Research, Chemistry, Neuro Discovery, Lead ID and Nonclinical. Best team I ever had the privilege of working with. You guys rock and this proves it. This merger is going to accelerate RNAi discovery and get innovative medicines to patients. So excited to get to work!

Congratulations, Dicerna Team!

Douglas Pagan

Chief Financial Officer / Chief Operating Officer at Jnana Therapeutics Inc.

2y

Fantastic outcome-congrats to all!

Douglas Fambrough

Investor and Board Member

2y

I am so happy and proud that Dicerna has become a Transformational Research Unit within Novo Nordisk!

Nancy Thomson PHR, SHRM-CP

Total Rewards & HR Operations Leader

2y

Congratulations to everyone!

Congratulations #MergerLinks #Pharmaceuticals #Healthcare

Like
Reply

Congratulations for this milestone, I wish you all a lot of success with the promising oligonucleotide modality!

Like
Reply
Hiroshi Fujiwara

Novo Nordisk - Senior Development Partner of Learning & Organization Development

2y

Congrats! Excellent news! This will make Novo be far more sofisticated firm from now on.

Like
Reply
Pedro Moreno

PhD | R&D | Drug Discovery & Development | Clinical Investigation | Product Management | Life Sciences Advisor

2y

Exciting to see what “this” future will bring for RNAi drug discovery

Like
Reply

Congratulations to all! This is an incredible milestone. More to come!!

See more comments

To view or add a comment, sign in

Explore topics